Clinical Study to Evaluate the Efficacy of Makandi in Hypertension of Geriatric Population

Hypertension has a widespread prevalence, is the most common psychosomatic disorder affecting 972 million people worldwide. The present clinical study deals with the effect of Makandi Ghana vati and tablet its powder in hypertension found in the geriatric age group (50 - 80 years). A total of 49 hypertensive patients fulfilling the diagnostic criteria were registered in two groups - Group I (Ghana vati) and Group II (Churna tablet). Out of 27 enrolled patients of group I, 21 patients completed the treatment. In Group II, out of 22 registered patients, a total of 20 patients completed the treatment. The effect of the therapy was assessed on the basis of changes in the systolic and diastolic blood pressures, in both sitting and supine positions; with Manasa Bhava Pariksha, Manasa Vibhrama Pariksha, symptomatology, geriatric signs and symptoms, and a brief psychiatric rating scale. Analysis of the results showed that the treatment in both the groups had been found to be good. It can be stated that Makandi, either in Ghana vati form or in churna tablet form, is an effective remedy for the treatment of hypertension. On analyzing the overall effect, 76.19% patients in Group I and 75.00% patients in Group II were mildly improved. Comparatively the overall treatment with group I was found to be better.